Literature DB >> 26689572

The impact of human immune deficiency virus and hepatitis C coinfection on white matter microstructural integrity.

J M Heaps-Woodruff1, P W Wright2, B M Ances2,3, D Clifford2, R H Paul4.   

Abstract

The purpose of the present study is to examine the integrity of white matter microstructure among individuals coinfected with HIV and HCV using diffusion tensor imaging (DTI). Twenty-five HIV+ patients, 21 HIV+/HCV+ patients, and 25 HIV- controls were included in this study. All HIV+ individuals were stable on combination antiretroviral therapy (cART; ≥3 months). All participants completed MRI and neuropsychological measures. Clinical variables including liver function, HIV-viral load, and CD4 count were collected from the patient groups. DTI metrics including mean diffusivity (MD), axial diffusivity (AD), radial diffusivity (RD), and fractional anisotropy (FA) from five subregions of the corpus callosum were compared across groups. The HIV+/HCV+ group and HIV+ group were similar in terms of HIV clinical variables. None of the participants met criteria for cirrhosis or fibrosis. Within the anterior corpus callosum, significant differences were observed between both HIV+ groups compared to HIV- controls on DTI measures. HIV+ and HIV+/HCV+ groups had significantly lower FA values and higher MD and RD values compared to HIV- controls; however, no differences were present between the HIV+ and HIV+/HCV+ groups. Duration of HIV infection was significantly related to DTI metrics in total corpus callosum FA only, but not other markers of HIV disease burden or neurocognitive function. Both HIV+ and HIV+/HCV+ individuals had significant alterations in white matter integrity within the corpus callosum; however, there was no evidence for an additive effect of HCV coinfection. The association between DTI metrics and duration of HIV infection suggests that HIV may continue to negatively impact white matter integrity even in well-controlled disease.

Entities:  

Keywords:  DTI; HCV; HIV; White matter

Mesh:

Substances:

Year:  2015        PMID: 26689572      PMCID: PMC4900914          DOI: 10.1007/s13365-015-0409-0

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  59 in total

1.  Whole brain diffusion tensor imaging in HIV-associated cognitive impairment.

Authors:  Ann B Ragin; Pippa Storey; Bruce A Cohen; Leon G Epstein; Robert R Edelman
Journal:  AJNR Am J Neuroradiol       Date:  2004-02       Impact factor: 3.825

2.  Topography of the human corpus callosum revisited--comprehensive fiber tractography using diffusion tensor magnetic resonance imaging.

Authors:  Sabine Hofer; Jens Frahm
Journal:  Neuroimage       Date:  2006-07-18       Impact factor: 6.556

3.  Regional cortical thinning associated with detectable levels of HIV DNA.

Authors:  Kalpana J Kallianpur; Gregory R Kirk; Napapon Sailasuta; Victor Valcour; Bruce Shiramizu; Beau K Nakamoto; Cecilia Shikuma
Journal:  Cereb Cortex       Date:  2011-10-19       Impact factor: 5.357

Review 4.  Central nervous system involvement in hepatitis C virus infection.

Authors:  Daniel M Forton; Howard C Thomas; Simon D Taylor-Robinson
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

5.  Neurocognitive functioning and HAART in HIV and hepatitis C virus co-infection.

Authors:  Thomas D Parsons; Karen A Tucker; Colin D Hall; Wendy T Robertson; Joseph J Eron; Michael W Fried; Kevin R Robertson
Journal:  AIDS       Date:  2006-08-01       Impact factor: 4.177

6.  Callosal degradation in HIV-1 infection predicts hierarchical perception: a DTI study.

Authors:  Eva M Müller-Oehring; Tilman Schulte; Margaret J Rosenbloom; Adolf Pfefferbaum; Edith V Sullivan
Journal:  Neuropsychologia       Date:  2009-12-16       Impact factor: 3.139

Review 7.  HCV/ HIV co-infection: time to re-evaluate the role of HIV in the liver?

Authors:  J T Blackard; K E Sherman
Journal:  J Viral Hepat       Date:  2008-01-17       Impact factor: 3.728

8.  Effects of active HCV replication on neurologic status in HIV RNA virally suppressed patients.

Authors:  D B Clifford; M Smurzynski; L S Park; T-M Yeh; Y Zhao; L Blair; M Arens; S R Evans
Journal:  Neurology       Date:  2009-07-28       Impact factor: 9.910

9.  Diffusion alterations in corpus callosum of patients with HIV.

Authors:  Y Wu; P Storey; B A Cohen; L G Epstein; R R Edelman; A B Ragin
Journal:  AJNR Am J Neuroradiol       Date:  2006-03       Impact factor: 3.825

10.  Clinicopathologic correlates of hepatitis C virus in brain: a pilot study.

Authors:  Jacinta Murray; Sarah L Fishman; Elizabeth Ryan; Francis J Eng; José L Walewski; Andrea D Branch; Susan Morgello
Journal:  J Neurovirol       Date:  2008-01       Impact factor: 2.643

View more
  12 in total

1.  Identifying the white matter impairments among ART-naïve HIV patients: a multivariate pattern analysis of DTI data.

Authors:  Zhenchao Tang; Zhenyu Liu; Ruili Li; Xin Yang; Xingwei Cui; Shuo Wang; Dongdong Yu; Hongjun Li; Enqing Dong; Jie Tian
Journal:  Eur Radiol       Date:  2017-04-10       Impact factor: 5.315

2.  Reliability of White Matter Microstructural Changes in HIV Infection: Meta-Analysis and Confirmation.

Authors:  E E O'Connor; A Jaillard; F Renard; T A Zeffiro
Journal:  AJNR Am J Neuroradiol       Date:  2017-06-08       Impact factor: 3.825

3.  The Use of Visual Rating Scales to Quantify Brain MRI Lesions in Patients with HIV Infection.

Authors:  Jessica Robinson-Papp; Allison Navis; Mandip S Dhamoon; Uraina S Clark; Jose Gutierrez-Contreras; Susan Morgello
Journal:  J Neuroimaging       Date:  2017-08-21       Impact factor: 2.486

4.  Associations of alcohol use, HIV infection, and age with brain white matter microstructure.

Authors:  Mollie A Monnig; Joseph M Gullett; Eric C Porges; Adam J Woods; Peter M Monti; Karen Tashima; Neda Jahanshad; Paul Thompson; Talia Nir; Ronald A Cohen
Journal:  J Neurovirol       Date:  2021-11-08       Impact factor: 3.739

Review 5.  Mechanisms of neuropathogenesis in HIV and HCV: similarities, differences, and unknowns.

Authors:  Ameer Abutaleb; Sarah Kattakuzhy; Shyam Kottilil; Erin O'Connor; Eleanor Wilson
Journal:  J Neurovirol       Date:  2018-10-05       Impact factor: 2.643

6.  Association of White Matter Hyperintensities With HIV Status and Vascular Risk Factors.

Authors:  Yair Mina; Tianxia Wu; Hsing-Chuan Hsieh; Dima A Hammoud; Swati Shah; Chuen-Yen Lau; Lillian Ham; Joseph Snow; Elizabeth Horne; Anuradha Ganesan; Stanley I Rapoport; Edmund C Tramont; Daniel S Reich; Brian K Agan; Avindra Nath; Bryan R Smith
Journal:  Neurology       Date:  2021-02-26       Impact factor: 9.910

7.  MR spectroscopy and diffusion imaging in people with human immunodeficiency virus: Relationships to clinical and immunologic findings.

Authors:  Susan Morgello; Korhan Buyukturkoglu; Jacinta Murray; Mike Veenstra; Joan W Berman; Desiree Byrd; Matilde Inglese
Journal:  J Neuroimaging       Date:  2021-09-14       Impact factor: 2.486

Review 8.  The Aging Brain With HIV Infection: Effects of Alcoholism or Hepatitis C Comorbidity.

Authors:  Natalie M Zahr
Journal:  Front Aging Neurosci       Date:  2018-03-22       Impact factor: 5.750

9.  Diffuse White Matter Signal Abnormalities on Magnetic Resonance Imaging Are Associated With Human Immunodeficiency Virus Type 1 Viral Escape in the Central Nervous System Among Patients With Neurological Symptoms.

Authors:  Ruthiran Kugathasan; Dami A Collier; Lewis J Haddow; Kate El Bouzidi; Simon G Edwards; Jonathan D Cartledge; Robert F Miller; Ravindra K Gupta
Journal:  Clin Infect Dis       Date:  2017-04-15       Impact factor: 9.079

10.  Preliminary Evidence for a Relationship between Elevated Plasma TNFα and Smaller Subcortical White Matter Volume in HCV Infection Irrespective of HIV or AUD Comorbidity.

Authors:  Natalie M Zahr; Kilian M Pohl; Allison J Kwong; Edith V Sullivan; Adolf Pfefferbaum
Journal:  Int J Mol Sci       Date:  2021-05-07       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.